225 related articles for article (PubMed ID: 37935827)
1. A Drosophila model relevant to chemotherapy-related cognitive impairment.
Torre M; Bukhari H; Nithianandam V; Zanella CA; Mata DA; Feany MB
Sci Rep; 2023 Nov; 13(1):19290. PubMed ID: 37935827
[TBL] [Abstract][Full Text] [Related]
2. A
Torre M; Bukhari H; Nithianandam V; Zanella CA; Mata DA; Feany MB
bioRxiv; 2023 Jun; ():. PubMed ID: 37333281
[TBL] [Abstract][Full Text] [Related]
3. Chemotherapy-related cognitive impairment in older patients with cancer.
Loh KP; Janelsins MC; Mohile SG; Holmes HM; Hsu T; Inouye SK; Karuturi MS; Kimmick GG; Lichtman SM; Magnuson A; Whitehead MI; Wong ML; Ahles TA
J Geriatr Oncol; 2016 Jul; 7(4):270-80. PubMed ID: 27197918
[TBL] [Abstract][Full Text] [Related]
4. Elevated Oxidative Stress and DNA Damage in Cortical Neurons of Chemotherapy Patients.
Torre M; Dey A; Woods JK; Feany MB
J Neuropathol Exp Neurol; 2021 Aug; 80(7):705-712. PubMed ID: 34363676
[TBL] [Abstract][Full Text] [Related]
5. Cisplatin-induced mitochondrial dysfunction is associated with impaired cognitive function in rats.
Lomeli N; Di K; Czerniawski J; Guzowski JF; Bota DA
Free Radic Biol Med; 2017 Jan; 102():274-286. PubMed ID: 27908784
[TBL] [Abstract][Full Text] [Related]
6. Clinical characteristics, pathophysiology, and management of noncentral nervous system cancer-related cognitive impairment in adults.
Wefel JS; Kesler SR; Noll KR; Schagen SB
CA Cancer J Clin; 2015 Mar; 65(2):123-38. PubMed ID: 25483452
[TBL] [Abstract][Full Text] [Related]
7. Doxorubicin and cisplatin induced cognitive impairment: The possible mechanisms and interventions.
Ongnok B; Chattipakorn N; Chattipakorn SC
Exp Neurol; 2020 Feb; 324():113118. PubMed ID: 31756316
[TBL] [Abstract][Full Text] [Related]
8. [Chemotherapy-related Cognitive Impairment in Patients with Hodgkin Lymphoma - Pathophysiology and Risk Factors].
Fayette D; Gahérová Ľ; Móciková H; Marková J; Kozák T; Horáček J
Klin Onkol; 2017; 30(2):93-99. PubMed ID: 28397504
[TBL] [Abstract][Full Text] [Related]
9. Replication and Meta-analysis of the Association between BDNF Val66Met Polymorphism and Cognitive Impairment in Patients Receiving Chemotherapy.
Tan CJ; Lim SWT; Toh YL; Ng T; Yeo A; Shwe M; Foo KM; Chu P; Jain A; Koo SL; Dent RA; Ng RCH; Yap YS; Lim EH; Loh KW; Chay WY; Lee GE; Tan TJY; Beh SY; Wong M; Chan JJ; Khor CC; Ho HK; Chan A
Mol Neurobiol; 2019 Jul; 56(7):4741-4750. PubMed ID: 30382534
[TBL] [Abstract][Full Text] [Related]
10. Propofol alleviates cisplatin-related cognitive impairment.
Zhou Y; Qiu Y
Neurol Sci; 2019 Aug; 40(8):1645-1649. PubMed ID: 31016408
[TBL] [Abstract][Full Text] [Related]
11. Cancer-related cognitive impairment: an update on state of the art, detection, and management strategies in cancer survivors.
Lange M; Joly F; Vardy J; Ahles T; Dubois M; Tron L; Winocur G; De Ruiter MB; Castel H
Ann Oncol; 2019 Dec; 30(12):1925-1940. PubMed ID: 31617564
[TBL] [Abstract][Full Text] [Related]
12. Cognitive Effects of Chemotherapy and Cancer-Related Treatments in Older Adults.
Vega JN; Dumas J; Newhouse PA
Am J Geriatr Psychiatry; 2017 Dec; 25(12):1415-1426. PubMed ID: 28495470
[TBL] [Abstract][Full Text] [Related]
13. Chemobrain in Breast Cancer: Mechanisms, Clinical Manifestations, and Potential Interventions.
Onzi GR; D'Agustini N; Garcia SC; Guterres SS; Pohlmann PR; Rosa DD; Pohlmann AR
Drug Saf; 2022 Jun; 45(6):601-621. PubMed ID: 35606623
[TBL] [Abstract][Full Text] [Related]
14. Mechanisms and Treatment for Cancer- and Chemotherapy-Related Cognitive Impairment in Survivors of Non-CNS Malignancies.
Chung NC; Walker AK; Dhillon HM; Vardy JL
Oncology (Williston Park); 2018 Dec; 32(12):591-8. PubMed ID: 30632128
[TBL] [Abstract][Full Text] [Related]
15. Managing Cancer and Living Meaningfully (CALM) alleviates chemotherapy related cognitive impairment (CRCI) in breast cancer survivors: A pilot study based on resting-state fMRI.
Yao S; Zhu Q; Zhang Q; Cai Y; Liu S; Pang L; Jing Y; Yin X; Cheng H
Cancer Med; 2023 Aug; 12(15):16231-16242. PubMed ID: 37409628
[TBL] [Abstract][Full Text] [Related]
16. Advances of neuroimaging in chemotherapy related cognitive impairment (CRCI) of patients with breast cancer.
Yao S; Zhang Q; Yao X; Zhang X; Pang L; Yu S; Cheng H
Breast Cancer Res Treat; 2023 Aug; 201(1):15-26. PubMed ID: 37329458
[TBL] [Abstract][Full Text] [Related]
17. Probiotic supplement attenuates chemotherapy-related cognitive impairment in patients with breast cancer: a randomised, double-blind, and placebo-controlled trial.
Juan Z; Chen J; Ding B; Yongping L; Liu K; Wang L; Le Y; Liao Q; Shi J; Huang J; Wu Y; Ma D; Ouyang W; Tong J
Eur J Cancer; 2022 Jan; 161():10-22. PubMed ID: 34896904
[TBL] [Abstract][Full Text] [Related]
18. Long-Term Cognitive Dysfunction in Cancer Survivors.
Országhová Z; Mego M; Chovanec M
Front Mol Biosci; 2021; 8():770413. PubMed ID: 34970595
[TBL] [Abstract][Full Text] [Related]
19. Associations of plasma brain-derived neurotrophic factor (BDNF) and Val66Met polymorphism (rs6265) with long-term cancer-related cognitive impairment in survivors of breast cancer.
Yap NY; Tan NYT; Tan CJ; Loh KW; Ng RCH; Ho HK; Chan A
Breast Cancer Res Treat; 2020 Oct; 183(3):683-696. PubMed ID: 32696315
[TBL] [Abstract][Full Text] [Related]
20. Cancer treatment induces neuroinflammation and behavioral deficits in mice.
Demos-Davies K; Lawrence J; Rogich A; Lind E; Seelig D
Front Behav Neurosci; 2022; 16():1067298. PubMed ID: 36699654
[No Abstract] [Full Text] [Related]
[Next] [New Search]
